213 related articles for article (PubMed ID: 8014009)
1. Molecular requirements for rapid plasmacytoma and pre-B lymphoma induction by Abelson murine leukemia virus in myc-transgenic mice.
Sugiyama H; Wang Y; Jackson P; Sawyers CL; Klein G
Int J Cancer; 1994 Jul; 58(1):135-41. PubMed ID: 8014009
[TBL] [Abstract][Full Text] [Related]
2. Abelson murine leukemia virus transforms preneoplastic Emu-myc transgene-carrying cells of the B-lymphocyte lineage into plasmablastic tumors.
Sugiyama H; Silva S; Wang YS; Weber G; Babonits M; Rosén A; Wiener F; Klein G
Int J Cancer; 1990 Nov; 46(5):845-52. PubMed ID: 2228313
[TBL] [Abstract][Full Text] [Related]
3. The accelerating role of Abelson murine leukemia virus in murine plasmacytoma development: in vitro infection of spleen cells generates donor-type tumors after transfer to pristane-treated BALB/c mice.
Sugiyama H; Weber G; Silva S; Babonits M; Wiener F; Klein G
Int J Cancer; 1989 Aug; 44(2):348-52. PubMed ID: 2547729
[TBL] [Abstract][Full Text] [Related]
4. Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas.
Weissinger EM; Mischak H; Goodnight J; Davidson WF; Mushinski JF
Mol Cell Biol; 1993 Apr; 13(4):2578-85. PubMed ID: 8455630
[TBL] [Abstract][Full Text] [Related]
5. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
[TBL] [Abstract][Full Text] [Related]
6. A retrovirus that expresses v-abl and c-myc oncogenes rapidly induces plasmacytomas.
Largaespada DA; Kaehler DA; Mishak H; Weissinger E; Potter M; Mushinski JF; Risser R
Oncogene; 1992 Apr; 7(4):811-9. PubMed ID: 1565479
[TBL] [Abstract][Full Text] [Related]
7. Recurring proviral integration suggests a role for proto-oncogene activation in thymomas induced with Mo-MuLV-rescued BCR/ABL virus.
Clark SS
Leukemia; 1997 Jul; 11(7):1026-33. PubMed ID: 9204986
[TBL] [Abstract][Full Text] [Related]
8. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras.
Silva S; Sugiyama H; Babonits M; Wiener F; Klein G
Int J Cancer; 1991 Sep; 49(2):224-8. PubMed ID: 1879968
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus.
Ohno S; Migita S; Wiener F; Babonits M; Klein G; Mushinski JF; Potter M
J Exp Med; 1984 Jun; 159(6):1762-77. PubMed ID: 6202819
[TBL] [Abstract][Full Text] [Related]
10. BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.
Clark SS; Chen E; Fizzotti M; Witte ON; Malkovska V
J Virol; 1993 Oct; 67(10):6033-46. PubMed ID: 8396667
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of myc-related oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane or Abelson murine leukemia virus.
Mushinski JF; Bauer SR; Potter M; Reddy EP
Proc Natl Acad Sci U S A; 1983 Feb; 80(4):1073-7. PubMed ID: 6302668
[TBL] [Abstract][Full Text] [Related]
12. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.
Rosenbaum H; Harris AW; Bath ML; McNeall J; Webb E; Adams JM; Cory S
EMBO J; 1990 Mar; 9(3):897-905. PubMed ID: 2155783
[TBL] [Abstract][Full Text] [Related]
13. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus.
Wiener F; Coleman A; Mock BA; Potter M
Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005
[TBL] [Abstract][Full Text] [Related]
14. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
Dyall-Smith D; Cory S
Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
[TBL] [Abstract][Full Text] [Related]
15. v-abl does not abolish IL-6 requirement by murine plasmacytoma cells.
Sugiyama H; Wiener F; Babonits M; Silva S; Hirano T; Kishimoto T; Klein G
Int J Cancer; 1991 May; 48(2):234-8. PubMed ID: 2019468
[TBL] [Abstract][Full Text] [Related]
16. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of v-abl uniquely cooperates with c-myc dysregulation in induction of plasma cell tumors, bypassing the need for T-lymphocytic help and overcoming T-lymphocytic interference.
Weissinger EM; Byrd LG; Henderson DW; Mushinski JF
Int J Cancer; 1996 Jul; 67(1):142-7. PubMed ID: 8690515
[TBL] [Abstract][Full Text] [Related]
18. ABL-MYC retroviral infection elicits bone marrow plasma cell tumors in Bcl-X(L) transgenic mice.
Linden M; Kirchhof N; Kvitrud M; Van Ness B
Leuk Res; 2005 Apr; 29(4):435-44. PubMed ID: 15725478
[TBL] [Abstract][Full Text] [Related]
19. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA
J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280
[TBL] [Abstract][Full Text] [Related]
20. Strain-related cellular mechanisms as a determinant for susceptibility and resistance to PC induction.
Sugiyama H; Silva S; Wang Y; Klein G
Curr Top Microbiol Immunol; 1995; 194():93-7. PubMed ID: 7895526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
